Toward a glioblastoma vaccine: promise and potential pitfalls.
Fine
Howard A
HA
D018109:Avulavirus; D019496:Cancer Vaccines / Q000494:pharmacology*; D016543:Central Nervous System Neoplasms / Q000276:immunology* / Q000628:therapy*; D005909:Glioblastoma / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D016233:Immunotherapy, Active; D011379:Prognosis; D015996:Survival Rate; D014407:Tumor Cells, Cultured
D019496:Cancer Vaccines